Hôpital Lariboisière

Hôpital Lariboisière is one of the most prominent teaching hospitals in Paris, established in 1854 during the Second French Empire. Located in the 10th arrondissement near Gare du Nord, it is part of AP-HP (Assistance Publique–Hôpitaux de Paris), the largest hospital system in Europe, serving over 10 million patients annually across 39 hospitals in the Paris region.

The hospital is a cornerstone of French academic medicine, combining clinical care with cutting-edge research and medical education. It is affiliated with Université Paris Cité and houses multiple INSERM (French National Institute of Health and Medical Research) units. France's healthcare system, ranked number one in the world by the World Health Organization, ensures that patients at Lariboisière benefit from universal coverage and some of the highest clinical standards globally.

Hôpital Lariboisière is nationally and internationally recognized for its centers of excellence in rheumatology, vascular surgery, emergency medicine, and addiction medicine. The hospital's rheumatology department is one of the largest in France, specializing in inflammatory joint diseases, osteoporosis, and musculoskeletal disorders. Its vascular surgery unit is a national reference center for aortic diseases and complex vascular reconstructions.

As part of the AP-HP network, the hospital benefits from shared resources, centralized research infrastructure, and access to a vast network of specialists. This integration ensures that patients with complex or rare conditions can be seamlessly referred to the most appropriate AP-HP facility for specialized care.

Hôpital Lariboisière, through the AP-HP international patient office, welcomes patients from around the world. Paris is one of the most accessible cities globally, served by two major international airports — Charles de Gaulle and Orly — with direct connections to virtually every continent. The hospital's location near Gare du Nord also provides excellent rail links via Eurostar and Thalys.

International patients benefit from dedicated multilingual coordinators who assist with appointment scheduling, medical record translation, visa documentation, and treatment planning. The hospital provides interpreter services in multiple languages and can arrange accommodation recommendations near the hospital. France's healthcare costs, while not the lowest, offer excellent value compared to the United States and Switzerland, with transparent pricing available upon request through the AP-HP international office.

Hopital Lariboisiere is one of Paris's most important clinical specialties hospitals, with strengths in emergency medicine, rheumatology, vascular surgery, and addiction medicine that reflect its history and its key role within the AP-HP (Assistance Publique, Hopitaux de Paris) network.

Emergency medicine is one of the hospital's defining functions. The emergency department is one of Paris's most active, handling a high volume of acute medical, surgical, and trauma presentations from the 10th arrondissement and across northern Paris. The department is staffed 24 hours a day with emergency physicians, surgeons, and anaesthesiologists, supported by rapid diagnostic capabilities and direct access to specialist inpatient teams.

Rheumatology is a center of excellence at Lariboisiere, recognized nationally for its expertise in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis), connective tissue diseases (lupus, vasculitis), and rare rheumatological conditions. The department is associated with Inserm research teams, contributing to new treatments for inflammatory and autoimmune diseases.

Vascular surgery covers aortic aneurysm repair (open and endovascular), carotid endarterectomy, peripheral arterial disease surgery, and venous surgery. Addiction medicine and clinical pharmacology are specialized programs that reflect the hospital's historical engagement with these medically complex populations. Cardiology, neurology, orthopedics, nephrology, endocrinology, and internal medicine provide comprehensive medical and surgical coverage for general hospital admissions.

Hopital Lariboisiere is located at 2 rue Ambroise Pare in the 10th arrondissement of Paris, close to the Gare du Nord, providing exceptional accessibility from across France and from the United Kingdom and Belgium via Eurostar and Thalys trains. The hospital occupies a distinctive Haussmann-era building constructed in 1854, combining historic architecture with modern clinical facilities developed through decades of investment.

The hospital operates inpatient wards across all major specialties. The emergency department is a large, modern facility equipped for immediate triage, resuscitation, and rapid assessment of all emergency presentations. The cardiac catheterization laboratory supports the cardiology department. The endoscopy suite provides diagnostic and therapeutic gastrointestinal endoscopy.

Surgical theatres support the vascular surgery, orthopedic, and general surgical programs. The rheumatology department operates dedicated infusion suites for biologic therapies used in inflammatory arthritis treatment. The addiction medicine program operates outpatient and inpatient treatment areas. Rehabilitation facilities support post-surgical recovery.

Diagnostic imaging is comprehensive, with CT, MRI, digital X-ray, ultrasound, and nuclear medicine. The clinical laboratory provides 24-hour analytical services as required for a major emergency receiving hospital. The hospital's proximity to the Gare du Nord makes it one of the most accessible major Paris hospitals for patients from outside the capital city.

Hopital Lariboisiere is part of AP-HP (Assistance Publique, Hopitaux de Paris), Europe's largest hospital system, and operates under AP-HP's comprehensive quality and governance framework. AP-HP hospitals undergo HAS (Haute Autorite de Sante) certification, France's national hospital quality accreditation, which evaluates all dimensions of hospital quality, patient safety, and governance on a regular cycle.

As a university hospital affiliated with Universite Paris Cite (formerly Paris Diderot University), Lariboisiere's medical education and research programs are accredited by the French university system. Medical residency and fellowship programs are nationally recognized and administered through the interregional medical residency matching system.

The hospital's research programs, particularly in rheumatology and addiction medicine, are conducted in partnership with INSERM (Institut National de la Sante et de la Recherche Medicale), France's national biomedical research institute, and comply with French and European regulations for human subjects research. GCP (Good Clinical Practice) standards govern all clinical trials conducted at the hospital.